Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
5 Big Biotech Stories to Watch
By Alexander Nicoll
Jul 18, 2018 3:07 PM EDT
PRESS RELEASES
Tonix Pharmaceuticals To Participate In BIO CEO & Investor Digital Conference
By GlobeNewswire
Feb 10, 2021 7:00 AM EST
PRESS RELEASES
Tonix Pharmaceuticals Holdings Corp. Closes $70M Common Stock Offering Priced At-The-Market Under Nasdaq Rules
By GlobeNewswire
Feb 9, 2021 4:05 PM EST
PRESS RELEASES
Tonix Pharmaceuticals Holdings Corp. Prices $70M Common Stock Offering Priced At-The-Market Under Nasdaq Rules
By GlobeNewswire
Feb 8, 2021 10:30 AM EST
PRESS RELEASES
Tonix Pharmaceuticals Announces Publication Of Patent Application For TNX-1500 (Monoclonal Antibody Anti-CD40-Ligand) In Development For Preventing And Treating Organ Transplant Rejection And Treating Autoimmune Conditions
By GlobeNewswire
Jan 14, 2021 7:00 AM EST
PRESS RELEASES
Tonix Pharmaceuticals Holdings Corp. Closes $40M Common Stock Offering Priced At-the-Market Under Nasdaq Rules
By GlobeNewswire
Jan 13, 2021 4:05 PM EST
PRESS RELEASES
Tonix Pharmaceuticals Holdings Corp. Prices $40M Common Stock Offering Priced At-the-Market Under Nasdaq Rules
By GlobeNewswire
Jan 11, 2021 12:59 PM EST
PRESS RELEASES
Tonix Pharmaceuticals Plans Commercial Scale Vaccine Manufacturing Facility
By GlobeNewswire
Dec 23, 2020 9:00 AM EST
PRESS RELEASES
Tonix Pharmaceuticals Reports Positive Immune Response Results From COVID-19 Vaccine Candidate TNX-1800, Following Vaccination Of Non-Human Primates
By GlobeNewswire
Nov 16, 2020 7:00 AM EST
PRESS RELEASES
Tonix Pharmaceuticals Outlines New Statistical Method To Analyze Future PTSD Studies At The 3rd Annual Neuropsychiatric Drug Development Summit
By GlobeNewswire
Nov 12, 2020 4:31 PM EST
PRESS RELEASES
Tonix Pharmaceuticals Enrolls First Participant In The PRECISION Study, An Observational Study To Facilitate Development Of Precision Medicine Techniques For COVID-19 Vaccines And Therapeutics
By GlobeNewswire
Oct 15, 2020 7:00 AM EDT
PRESS RELEASES
Tonix Pharmaceuticals To Participate In BIO Investor Forum Digital
By GlobeNewswire
Oct 7, 2020 7:00 AM EDT
PRESS RELEASES
Tonix Pharmaceuticals Announces Plan To Complete The Phase 3 RELIEF Study Of TNX-102 SL For Management Of Fibromyalgia With Currently Enrolled Participants Based On Results Of Interim Analysis
By GlobeNewswire
Sep 29, 2020 4:05 PM EDT
PRESS RELEASES
Tonix Pharmaceuticals Completes Purchase Of Facility To House Advanced Development Center (ADC) For Vaccine Programs
By GlobeNewswire
Sep 28, 2020 4:15 PM EDT
PRESS RELEASES
Tonix Pharmaceuticals Enrolls First Patient In COV-LOGIC, An Observational Study To Assess Antibody And T Cell Responses To SARS-CoV-2, The Virus That Causes COVID-19
By GlobeNewswire
Sep 15, 2020 9:00 AM EDT
PRESS RELEASES
Tonix Pharmaceuticals Initiates Enrollment In Second Potentially Pivotal Phase 3 Study, The RALLY Study, Of TNX-102 SL For The Management Of Fibromyalgia
By GlobeNewswire
Sep 3, 2020 9:00 AM EDT
PRESS RELEASES
Tonix Pharmaceuticals Announces Clearance Of IND For TNX-102 SL For Treatment Of Alcohol Use Disorder
By GlobeNewswire
Aug 6, 2020 9:00 AM EDT
PRESS RELEASES
Tonix Pharmaceuticals Regains Compliance With NASDAQ Minimum Bid Price Requirement
By GlobeNewswire
Aug 4, 2020 9:00 AM EDT
PRESS RELEASES
Tonix Pharmaceuticals Announces That Results From A Preclinical Study Of TNX-1900 Are Posted At The AAN Sports Concussion Virtual Conference
By GlobeNewswire
Aug 4, 2020 7:00 AM EDT
PRESS RELEASES
Tonix Pharmaceuticals To Participate In SNN Network Virtual Investor Conference
By GlobeNewswire
Jul 30, 2020 7:00 AM EDT
PRESS RELEASES
Tonix Pharmaceuticals Announces That Results From A Preclinical Study Of TNX-1900 Will Be Presented In A Poster At The AAN Sports Concussion Virtual Conference
By GlobeNewswire
Jul 27, 2020 7:00 AM EDT
PRESS RELEASES
Tonix Pharmaceuticals Holding Corp. Announces Rescheduling Of Special Meeting Of Stockholders
By GlobeNewswire
Jul 21, 2020 4:45 PM EDT
PRESS RELEASES
Tonix Pharmaceuticals Announces Research Collaboration To Develop Precision Medicine Techniques For COVID-19 Vaccines And Therapeutics
By GlobeNewswire
Jul 16, 2020 9:00 AM EDT
PRESS RELEASES
Tonix Pharmaceuticals Holding Corp. Closes $10.5 Million Common Stock Registered Direct Offering
By GlobeNewswire
Jul 15, 2020 5:00 PM EDT
STOCKS
5 Big Biotech Stories to Watch
By Alexander Nicoll
Jul 18, 2018 3:07 PM EDT
